{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:14:50Z","timestamp":1781043290387,"version":"3.54.1"},"reference-count":117,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.autrev.2024.103675","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T20:15:49Z","timestamp":1730319349000},"page":"103675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back"],"prefix":"10.1016","volume":"23","author":[{"given":"Ant\u00f3nio","family":"Lamas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103675_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0010","doi-asserted-by":"crossref","first-page":"38R","DOI":"10.1203\/PDR.0b013e31819dbd0a","article-title":"An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum","volume":"65","author":"McGonagle","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2024.103675_bb0015","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s10067-018-4209-9","article-title":"From autoinflammation to autoimmunity: old and recent findings","volume":"37","author":"Caso","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.berh.2018.02.001","article-title":"Juvenile-onset systemic lupus erythematosus (jSLE) \u2013 pathophysiological concepts and treatment options","volume":"31","author":"Hedrich","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43162-021-00040-5","article-title":"Bridging autoinflammatory and autoimmune diseases","volume":"33","author":"El-Shebiny","year":"2021","journal-title":"Egypt J Intern Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaad.2020.04.150","article-title":"The history of lupus throughout the ages","volume":"87","author":"Felten","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005792-195412000-00001","article-title":"Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases","volume":"33","author":"Harvey","year":"1954","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2024.103675_bb0040","series-title":"Clinical Epidemiology of Systemic Lupus Erythematosus in the North of Portugal\/Epidemiologia cl\u00ednica do l\u00fapus eritematosos sist\u00e9mico do norte de Portugal","author":"Vasconcelos","year":"2007"},{"key":"10.1016\/j.autrev.2024.103675_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00011-022-01554-6","article-title":"Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus","volume":"71","author":"Bolouri","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.autrev.2024.103675_bb0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103675_bb0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41467-021-21049-y","article-title":"Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103675_bb0060","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7326\/0003-4819-95-3-322","article-title":"Lupus erythematosus-like syndrome with selective complete deficiency of C1q","volume":"95","author":"Nishino","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0070","first-page":"106","article-title":"SLE like syndrome and functional deficiency of C1q in members of a large family","volume":"55","author":"Hannema","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","article-title":"Monogenic lupus: it\u2019s all new!","volume":"49","author":"Costa-Reis","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jbspin.2018.10.007","article-title":"Rare diseases that mimic systemic lupus erythematosus (Lupus mimickers)","volume":"86","author":"Chasset","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103675_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","article-title":"Deficiency of adenosine deaminase 2 causes antibody deficiency","volume":"36","author":"Schepp","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0090","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103675_bb0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3389\/fimmu.2017.00497","article-title":"Toward an inclusive, congruent, and precise definition of autoinflammatory diseases","volume":"8","author":"Wekell","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0110","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.lpm.2018.12.003","article-title":"Autoinflammatory diseases: state of the art","volume":"48","author":"Georgin-Lavialle","year":"2019","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41584-020-0377-5","article-title":"Moving towards a systems-based classification of innate immune-mediated diseases","volume":"16","author":"Savic","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102774","article-title":"Systemic autoinflammatory disease in adults","volume":"20","author":"Betrains","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103675_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000550","article-title":"Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases","volume":"3","author":"Savic","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2024.103675_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103675_bb0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2024.103675_bb0140","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.18822","article-title":"Exploring macrophage activation syndrome secondary to systemic lupus erythematosus in adults: a systematic review of the literature","author":"Aziz","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2024.103675_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.010","article-title":"Inflammasomes and autoimmune and rheumatic diseases: a comprehensive review","volume":"103","author":"Shin","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103675_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.autrev.2024.103675_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphar.2019.00435","article-title":"P2X7 receptor expression in patients with Serositis related to systemic lupus erythematosus","volume":"10","author":"Furini","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2024.103675_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.reuma.2019.10.007","article-title":"Role of Inflammasome activation in systemic lupus erythematosus: are innate immune cells activated?","volume":"17","author":"Perez-Alamino","year":"2021","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.autrev.2024.103675_bb0165","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.1103355","article-title":"U1-small nuclear ribonucleoprotein activates the NLRP3 Inflammasome in human monocytes","volume":"188","author":"Shin","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0170","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.1201195","article-title":"Self double-stranded (ds)DNA induces IL-1\u03b2 production from human monocytes by activating NLRP3 Inflammasome in the presence of anti\u2013dsDNA antibodies","volume":"190","author":"Shin","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916934.2011.637532","article-title":"Polimorphisms in Inflammasome genes are involved in the predisposition to systemic lupus erythematosus","volume":"45","author":"Pontillo","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103675_bb0190","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.40155","article-title":"Podocyte activation of NLRP3 Inflammasomes contributes to the development of proteinuria in lupus nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0195","first-page":"680","article-title":"Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis","volume":"38","author":"Huang","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1139\/bcb-2020-0265","article-title":"Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL\/Faslpr mice through ameliorating inflammation via the PKC\u03b4\u2013NLRC4 axis","volume":"99","author":"Yang","year":"2021","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2024.103675_bb0205","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2340\/00015555-3197","article-title":"Systemic lupus erythematosus with familial Mediterranean fever: case report and review of literature","volume":"99","author":"Kokubu","year":"2019","journal-title":"Acta Derm Venerol"},{"key":"10.1016\/j.autrev.2024.103675_bb0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.reuma.2022.04.002","article-title":"Co-occurrence of familial Mediterranean fever with systemic lupus erythematosus in south Asian population","volume":"19","author":"Farooq","year":"2023","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.autrev.2024.103675_bb0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/09612033211004726","article-title":"The coexistence of familial Mediterranean fever (FMF) in systemic lupus erythematosus (SLE) patients \u2013 a cross sectional study","volume":"30","author":"Klein","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0220","first-page":"442","article-title":"The presence of P2RX7 single nuclear polymorphism is associated with a gain of function in P2X7 receptor and inflammasome activation in SLE complicated with pericarditis","volume":"38","author":"Hu","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0225","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0230","first-page":"334","article-title":"Recurrent lupus pericarditis treated with Anakinra - a case report","volume":"1","author":"Oliveira Pinheiro","year":"2022","journal-title":"ARP Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105299","article-title":"Anakinra effectiveness in refractory polyserositis: an Italian multicenter study","volume":"89","author":"Lopalco","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103675_bb0240","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00393-020-00836-w","article-title":"Macrophage activation syndrome triggered by active systemic lupus erythematosus: successful treatment by interleukin-1 inhibition (anakinra)","volume":"79","author":"K\u00fcbler","year":"2020","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0245","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/1756-185X.14722","article-title":"Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: a case report and description of a novel therapeutic regimen","volume":"26","author":"Xu","year":"2023","journal-title":"Int J of Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103675_bb0250","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.3782","article-title":"Anakinra for recurrent fevers in systemic lupus erythematosus","author":"Dein","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2024.103675_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.autrev.2024.103675_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574992","article-title":"Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) with disrupted domains of A20","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629457","article-title":"Case report: a novel TNFAIP3 mutation causing Haploinsufficiency of A20 with a lupus-like phenotype","volume":"12","author":"Shaheen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.05.001","article-title":"Increased expression of toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs","volume":"61","author":"Lyn-Cook","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103675_bb0280","article-title":"Association of Toll-like Receptor 7 (TLR7) polymorphisms with predisposition to systemic lupus erythematosus (SLE): a Meta and trial sequential analysis","author":"Ranjan","year":"2023","journal-title":"Biochem Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-immunol-051116-052225","article-title":"Understanding human autoimmunity and autoinflammation through transcriptomics","volume":"35","author":"Banchereau","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11741","article-title":"Interferon in systemic lupus erythematosus\u2014a halfway between monogenic autoinflammatory and autoimmune disease","volume":"8","author":"Saulescu","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.autrev.2024.103675_bb0295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0300","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0961203313486950","article-title":"Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy","volume":"22","author":"Troedson","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0305","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon\u2013mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0310","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.40002","article-title":"Expression of cyclic GMP-AMP synthase in patients with systemic lupus erythematosus","volume":"69","author":"An","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0315","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103675_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1046687","article-title":"Targeting type I interferons in systemic lupus erythematous","volume":"13","author":"Bruera","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2024.103675_bb0325","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized Immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103675_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101949","article-title":"Classification of systemic lupus erythematosus: from the development of classification criteria to a new taxonomy?","volume":"37","author":"Aringer","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0335","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Gouti\u00e8res syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0340","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0345","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2024.103675_bb0350","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3390\/cells11030318","article-title":"Lung inflammation in STING-associated vasculopathy with onset in infancy (SAVI)","volume":"11","author":"David","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103675_bb0355","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.reuma.2016.01.005","article-title":"Systemic lupus erythematosus: is it one disease?","volume":"12","author":"Rivas-Larrauri","year":"2016","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.autrev.2024.103675_bb0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2478\/rir-2021-0019","article-title":"Systemic lupus erythematosus and immunodeficiency","volume":"2","author":"Chan","year":"2021","journal-title":"Rheumatol Immunol Res"},{"key":"10.1016\/j.autrev.2024.103675_bb0365","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41379-018-0015-9","article-title":"Inflammatory and infectious manifestations of immunodeficiency in the gastrointestinal tract","volume":"31","author":"Panarelli","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2024.103675_bb0370","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.it.2015.12.006","article-title":"Primary Immunodeficiencies and inflammatory disease: a growing genetic intersection","volume":"37","author":"Fodil","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0375","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/aei.v49i6.450","article-title":"Experience of autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies","volume":"49","author":"\u00d6zcan","year":"2021","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.autrev.2024.103675_bb0385","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s10875-021-01084-6","article-title":"Chronically activated T-cells retain their inflammatory properties in common variable immunodeficiency","volume":"41","author":"Berbers","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0390","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2022.12.807","article-title":"Contribution of genetic variants associated with primary immunodeficiencies to childhood-onset systemic lupus erythematous","volume":"151","author":"Wu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0395","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0400","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0405","first-page":"7","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0598-3","article-title":"The lupus paradox","volume":"19","author":"Carroll","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0415","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","article-title":"Primary immunodeficiency and autoimmunity: lessons from human diseases","volume":"71","author":"Arason","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0420","first-page":"1128","article-title":"Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus","volume":"21","author":"Sullivan","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0425","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2024.103675_bb0430","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1756-185X.12254","article-title":"Prolidase deficiency breaks tolerance to lupus-associated antigens","volume":"16","author":"Kurien","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103675_bb0435","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.rbr.2015.03.002","article-title":"Primary immunodeficiency association with systemic lupus erythematosus: review of literature and lessons learned by the rheumatology division of a tertiary university hospital at S\u00e3o Paulo","volume":"56","author":"Errante","year":"2016","journal-title":"Brazil Rev Brasil Reumatol"},{"key":"10.1016\/j.autrev.2024.103675_bb0440","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2020.03.006","article-title":"Variable immunodeficiency study: evaluation of two European cohorts within a variety of clinical phenotypes","volume":"223","author":"Guevara-Hoyer","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2024.103675_bb0445","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0961203307077543","article-title":"Selective IgA deficiency in children and adults with systemic lupus erythematosus","volume":"16","author":"Cassidy","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0450","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/0961203311411598","article-title":"Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients","volume":"20","author":"Jesus","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0455","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11033-012-2075-0","article-title":"Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"40","author":"Xiang","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2024.103675_bb0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clim.2017.06.009","article-title":"Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome","volume":"183","author":"Agrebi","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0465","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune lymphoproliferative syndrome\u2013like disease with somatic KRAS mutation","volume":"117","author":"Takagi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103675_bb0470","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical Spectrum of Ras-associated autoimmune Leukoproliferative disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0475","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.033","article-title":"Probable autoimmune lymphoproliferative syndrome with monogenic lupus due to KRAS mutation - a rare encounter","volume":"16","author":"Nayak","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.autrev.2024.103675_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385190","article-title":"One gene to rule them all \u2013 clinical perspectives of a potent suppressor of cytokine signaling \u2013 SOCS1","volume":"15","author":"K\u00f6rholz","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0485","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103675_bb0490","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s10875-023-01460-4","article-title":"Phenotypic variability of SOCS1 Haploin sufficiency","volume":"43","author":"Hale","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0495","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajhg.2012.02.023","article-title":"Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study","volume":"90","author":"Lessard","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0500","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ejhg.2012.277","article-title":"Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations","volume":"21","author":"Wang","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2024.103675_bb0505","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/ijms25010452","article-title":"Helios as a potential biomarker in systemic lupus erythematosus and new therapies based on immunosuppressive cells","volume":"25","author":"Par\u00eds-Mu\u00f1oz","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.autrev.2024.103675_bb0510","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1038\/s41598-022-13336-5","article-title":"Omics-based integrated analysis identified IKZF2 as a biomarker associated with lupus nephritis","volume":"12","author":"Zhou","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2024.103675_bb0515","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJMoa2106535","article-title":"Phase 2 trial of Iberdomide in systemic lupus erythematosus","volume":"386","author":"Merrill","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103675_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe3981","article-title":"Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity","volume":"6","author":"Shahin","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0525","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/bloodadvances.2021006367","article-title":"Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation","volume":"6","author":"Shahin","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2024.103675_bb0530","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/art.38008","article-title":"Protein kinase C\u03b4 deficiency causes Mendelian systemic lupus erythematosus with B cell-defective apoptosis and Hyperproliferation","volume":"65","author":"Belot","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103675_bb0535","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10875-016-0323-0","article-title":"Protein kinase C \u03b4: a gatekeeper of immune homeostasis","volume":"36","author":"Salzer","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0540","first-page":"3","article-title":"APECED: is this a model for failure of T cell and B cell tolerance?","author":"Kluger","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0545","article-title":"A case report and literature review: identification of a novel AIRE gene mutation associated with autoimmune Polyendocrine syndrome type 1 in east Asians","volume":"99","author":"Yan","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2024.103675_bb0550","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-3083.2010.02486.x","article-title":"TSGA10 \u2013 a target for autoantibodies in autoimmune Polyendocrine syndrome type 1 and systemic lupus erythematosus","volume":"73","author":"Smith","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0555","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","article-title":"IPEX syndrome from diagnosis to cure, learning along the way","volume":"153","author":"Bacchetta","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103675_bb0560","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jcm13041092","article-title":"Inflammatory complications in chronic granulomatous disease","volume":"13","author":"Grammatikos","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.autrev.2024.103675_bb0565","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0961203308095000","article-title":"Systemic lupus erythematosus and Wiskott-Aldrich syndrome in an Italian patient","volume":"18","author":"Monteferrante","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103675_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103675_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-5699(89)90245-4","article-title":"The mosaic of autoimmunity","volume":"10","author":"Shoenfeld","year":"1989","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2024.103675_bb0580","series-title":"The mosaic of autoimmunity: The factors associated with autoimmune disease","author":"Shoenfeld","year":"1990"},{"key":"10.1016\/j.autrev.2024.103675_bb0585","series-title":"Mosaic of autoimmunity: The novel factors of autoimmune diseases","year":"2019"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:14:14Z","timestamp":1732677254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":117,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1568997224001666"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103675","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103675"}}